GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cansortium Inc (XCNQ:TIUM.U) » Definitions » Marketable Securities

Cansortium (XCNQ:TIUM.U) Marketable Securities : $0.0 Mil (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cansortium Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Cansortium's Marketable Securities for the quarter that ended in Sep. 2024 was $0.0 Mil.

Cansortium's annual Marketable Securities declined from Dec. 2021 ($0.2 Mil) to Dec. 2022 ($0.0 Mil) but then stayed the same from Dec. 2022 ($0.0 Mil) to Dec. 2023 ($0.0 Mil).


Cansortium Marketable Securities Historical Data

The historical data trend for Cansortium's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cansortium Marketable Securities Chart

Cansortium Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial - 0.20 0.20 - -

Cansortium Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cansortium Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Cansortium  (XCNQ:TIUM.U) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Cansortium Marketable Securities Related Terms

Thank you for viewing the detailed overview of Cansortium's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Cansortium Business Description

Traded in Other Exchanges
Address
82 North East 26th Street, Unit 110, Miami, FL, USA, 33137
Cansortium Inc is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flowers, pre-rolls, cartridges, and edibles. All of the company's products are marketed under the Fluent brand name. In Pennsylvania, the company's product portfolio is comprised of a variety of third-party branded medical cannabis products.

Cansortium Headlines

No Headlines